Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma

CONCLUSION: Lean patients with cirrhosis and HCC present with larger tumors and are more often outside Milan criteria, reflecting cancer related cachexia from delayed diagnosis. Access to care for hepatitis C virus therapy and liver transplantation confer a survival benefit, but not overweight or obese BMI classifications.PMID:38577534 | PMC:PMC10989303 | DOI:10.4254/wjh.v16.i3.393

Source: World Journal of Hepatology - April 5, 2024 Category: Gastroenterology Authors: Andrew Scott deLemos Jing Zhao Milin Patel Banks Kooken Karan Mathur Hieu Minh Nguyen Areej Mazhar Maggie McCarter Heather Burney Carla Kettler Naga Chalasani Samer Gawrieh Source Type: research